SBIR/STTR Research Award
SBIR Phase II: Tissue Engineered Cartilage for Drug Discovery
Award amount
$499,914Program and phase
SBIR · Phase IIAward year
2004Award details
- Awarding agency
- National Science Foundation
- Branch
- Not reported
- Recipient company
- ARTICULAR ENGINEERING, LLC
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
This Small Business Innovation Research Phase II project is to develop scale-up production technology to produce engineered cartilage for drug discovery using a proprietary Alginate Recovered Chondrocyte (ARC) method. This method stimulates adult human cartilage cells to form a cartilaginous tissue with proper compositional and functional properties. ARC cartilage tissue is expected to offer a cost-effective alternative to current culture systems and expensive animal studies while utilizing human tissue.
The commercial application of this project will be in the area of drug discovery for cartilage-related problems such as rheumatoid arthritis.
Technology keywords
Not reported